Evolution and host-specific adaptation of Pseudomonas aeruginosa

Affiliations
  • 1Victor Phillip Dahdaleh Heart & Lung Research Institute, University of Cambridge, Cambridge, UK.
  • 2University of Cambridge Molecular Immunity Unit, MRC Laboratory of Molecular Biology, Cambridge, UK.
  • 3Cambridge Centre for AI in Medicine, University of Cambridge, Cambridge, UK.
  • 4Department of Veterinary Medicine, University of Cambridge, Cambridge, UK.
  • 5Laboratory of Pathogens and Host Immunity (LPHI), UMR5235, CNRS/Université de Montpellier, Montpellier, France.
  • 6Cambridge Centre for Lung Infection, Royal Papworth Hospital, Cambridge, UK.
  • 7Department of Physiology, Bioscience Institute, University College Cork, Cork, Ireland.
  • 8Department of Biochemistry, University of Cambridge, Cambridge, UK.
  • 9Department of Medicine, University of Cambridge, Cambridge, UK.
  • 10Wellcome Sanger Institute, Hinxton, UK.
  • 11Cambridge University Hospitals Trust, Cambridge, UK.
  • 12Institut de Biologie Intégrative et des Systèmes (IBIS), Université Laval, Québec City, Québec, Canada.
  • 13Department of Science, University Roma Tre, Rome, Italy.
  • 14IRCCS Fondazione Santa Lucia, Rome, Italy.
  • 15London School of Hygiene and Tropical Medicine, London, UK.
  • 16Department of Clinical Infection, Microbiology and Immunology, University of Liverpool, Liverpool, UK.

Published on:

Abstract

The major human bacterial pathogen causes multidrug-resistant infections in people with underlying immunodeficiencies or structural lung diseases such as cystic fibrosis (CF). We show that a few environmental isolates, driven by horizontal gene acquisition, have become dominant epidemic clones that have sequentially emerged and spread through global transmission networks over the past 200 years. These clones demonstrate varying intrinsic propensities for infecting CF or non-CF individuals (linked to specific transcriptional changes enabling survival within macrophages); have undergone multiple rounds of convergent, host-specific adaptation; and have eventually lost their ability to transmit between different patient groups. Our findings thus explain the pathogenic evolution of and highlight the importance of global surveillance and cross-infection prevention in averting the emergence of future epidemic clones.

Related Concept Videos

JoVE Research Video for Defense Against Bacterial Pathogens 01:31

689

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol…

JoVE Research Video for Limits to Natural Selection 01:38

29.6K

Organisms that are well-adapted to their environment are more likely to survive and reproduce. However, natural selection does not lead to perfectly adapted organisms. Several factors constrain natural selection.

For one, natural selection can only act upon existing genetic variation. Hypothetically, red tusks may enhance elephant survival by deterring ivory-seeking poachers. However, if there are no gene variants—or alleles—for red tusks, natural selection cannot…

JoVE Research Video for Antibiotic Selection 00:57

50.8K

Overview

Researchers use antibiotic resistance genes to identify bacteria that possess a plasmid containing their gene of interest. Antibiotic resistance naturally occurs when a spontaneous DNA mutation creates changes in bacterial genes that eliminate antibiotic activity. Bacteria can share these new resistance genes with their offspring and other bacteria. The overuse and misuse of antibiotics have created a public health crisis, as resistant and multi-resistant bacteria continue to develop.<br…